Meningitis B Outbreak in Kent, UK: What You Need to Know

An outbreak of invasive meningococcal disease, specifically strain MenB, is currently underway in Kent, England, prompting health officials to issue alerts and offer preventative measures. As of March 18, 2026, at least 20 cases have been identified since March 13, tragically resulting in two deaths. This article provides the latest information on the outbreak, symptoms, and preventative steps.

What is Meningococcal Disease?

Meningococcal disease is a serious, though uncommon, illness caused by meningococcal bacteria. It can lead to meningitis – inflammation of the protective membranes surrounding the brain and spinal cord – and sepsis (blood poisoning). The rapid onset of symptoms makes quick recognition and action crucial. There are several strains of meningococcal bacteria, including MenA, MenB, MenC, MenW, MenX, and MenY. The current outbreak is linked to the MenB strain. [UKHSA]

Outbreak Details: Kent, England

The UK Health Security Agency (UKHSA) first identified 15 cases of invasive meningococcal disease in the South East between March 13 and March 16, 2026. [NHS England] Four of these cases have been confirmed as meningococcal group B. The majority of cases involve students from the University of Kent in Canterbury and sixth-form students from local secondary schools.

Investigations have identified potential exposure sites, including Club Chemistry, a nightclub in Canterbury, between March 5 and March 7. The University of Kent is also being investigated, with UKHSA following up with staff and students. [Modern York Times] One case of invasive meningococcal disease possibly linked to the outbreak has been reported in France. [ECDC]

How is Meningococcal Disease Spread?

Transmission of MenB requires close and prolonged contact, such as living in the same household or through intimate contact like kissing or sharing drinks or vapes. It is not as easily spread as viruses like measles or COVID-19. [UKHSA]

Symptoms of Meningococcal Disease

Symptoms of meningococcal disease can develop rapidly and include:

• High fever
• Severe headache
• Stiff neck
• Nausea and vomiting
• Sensitivity to light
• Confusion or disorientation
• Rash (may appear as small, red or purple spots)

It’s essential to note that not everyone will experience all of these symptoms, and the order in which they appear can vary.

Who is Being Offered Preventative Treatment?

Antibiotic prophylaxis (preventative antibiotics) is being offered to:

• Anyone who attended Club Chemistry in Canterbury, Kent on March 5, 6, or 7.
• Close contacts of confirmed or suspected cases.
• Students living on the Canterbury campus of the University of Kent.
• Staff who live or function in affected halls of residence at the University of Kent.

If you have been offered preventative antibiotics, it is strongly recommended that you take them promptly. [UKHSA] Local clinics are providing chemoprophylaxis to contacts in the Canterbury area, and prescriptions are available for individuals who have returned home and not yet received prophylaxis.

Risk to the EU/EEA

The European Centre for Disease Prevention and Control (ECDC) assesses the risk to the general population in the European Union and European Economic Area (EU/EEA) as very low due to the limited probability of exposure and infection. [ECDC] However, if a case linked to the outbreak is detected in the EU/EEA, prompt control measures, including identifying close contacts and administering antibiotic prophylaxis and MenB vaccination, should be initiated.

Key Takeaways

• An outbreak of Meningococcal B disease is occurring in Kent, England.
• The outbreak is linked to the University of Kent and a nightclub in Canterbury.
• Symptoms develop rapidly and can be severe.
• Antibiotic prophylaxis is available for those potentially exposed.
• The risk to the EU/EEA is currently very low.